Replies to post #28135 on Intellipharmaceutics International Inc. (IPCI)

[kei]

the reason why i asked is that under New FDA Chief (Trump administration), drugs in issues are much easier and faster to get FDA approval - in other wards, upcoming advisory committee (26th) will be the key since those committee members are from outside of the FDA (sometimes retired-fda doctors) - i think if IPCI gets favorable opinions from ad.comm, the approval chance will be really high & the pps might hit X2 or even higher. .. btw, briefing doc will be out on 24th (Monday) - good luck to all